Relief Therapeutics Holding SA (RLFTF)
1.39
-0.01
(-0.71%)
USD |
OTCM |
May 03, 16:00
Relief Therapeutics Market Cap: 16.98M for May 3, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 03, 2024 | 16.98M |
| May 02, 2024 | 17.11M |
| May 01, 2024 | 17.11M |
| April 30, 2024 | 17.11M |
| April 29, 2024 | 17.59M |
| April 26, 2024 | 17.72M |
| April 25, 2024 | 17.72M |
| April 24, 2024 | 17.72M |
| April 23, 2024 | 17.72M |
| April 22, 2024 | 17.72M |
| April 19, 2024 | 17.72M |
| April 18, 2024 | 17.47M |
| April 17, 2024 | 17.11M |
| April 16, 2024 | 16.49M |
| April 15, 2024 | 16.13M |
| April 12, 2024 | 17.72M |
| April 11, 2024 | 17.72M |
| April 10, 2024 | 18.33M |
| April 09, 2024 | 17.72M |
| April 08, 2024 | 17.75M |
| April 05, 2024 | 18.33M |
| April 04, 2024 | 17.47M |
| April 03, 2024 | 16.80M |
| April 02, 2024 | 17.72M |
| April 01, 2024 | 17.59M |
| Date | Value |
|---|---|
| March 28, 2024 | 17.72M |
| March 27, 2024 | 18.94M |
| March 26, 2024 | 19.06M |
| March 25, 2024 | 20.04M |
| March 22, 2024 | 19.52M |
| March 21, 2024 | 17.90M |
| March 20, 2024 | 19.67M |
| March 19, 2024 | 19.55M |
| March 18, 2024 | 19.55M |
| March 15, 2024 | 19.06M |
| March 14, 2024 | 19.55M |
| March 13, 2024 | 20.04M |
| March 12, 2024 | 20.04M |
| March 11, 2024 | 20.53M |
| March 08, 2024 | 20.41M |
| March 07, 2024 | 21.26M |
| March 06, 2024 | 20.89M |
| March 05, 2024 | 19.18M |
| March 04, 2024 | 20.89M |
| March 01, 2024 | 21.63M |
| February 29, 2024 | 21.38M |
| February 28, 2024 | 21.99M |
| February 27, 2024 | 22.60M |
| February 26, 2024 | 22.60M |
| February 23, 2024 | 23.34M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
16.13M
Minimum
Apr 15 2024
2.045B
Maximum
Feb 08 2021
400.96M
Average
144.52M
Median
Market Cap Benchmarks
| AC Immune SA | 236.37M |
| CRISPR Therapeutics AG | 4.744B |
| Addex Therapeutics Ltd | 9.566M |
| NLS Pharmaceutics Ltd | 5.978M |
| Molecular Partners AG | 130.76M |
Market Cap Related Metrics
| PS Ratio | 2.417 |
| PEG Ratio | -0.0013 |
| Price to Book Value | 0.2731 |
| Price | 1.39 |
| Earnings Yield | -672.4% |
| PEGY Ratio | -0.0013 |